Germline pathogenic DROSHA variants are linked to pineoblastoma and Wilms tumor predisposition.
Fiorica PN, Golmard L, Kim J, Bao R, Lin FY, Roy A, Pribnow A, Perrino MR, Masliah-Planchon J, Michalak-Provost S, Wong J, Filser M, Stoppa-Lyonnet D, Bourdeaut F, Brahimi A, Ingster O, Saulnier Sholler G, Jackson SA, Sasaki MM, Fowler T, Ng A, Corbett RJ, Kaufman RS, Haley JS, Carey DJ, Huang KL, Diskin SJ, Rokita JL, Al-Kateb H, McGee RB, Schiffman JD, Chen KS, Stewart DR, Williams Parsons D, Plon SE, Schultz KAP, Onel K, 2025 Feb Clin Cancer ResDROSHA regulates mesenchymal gene expression in Wilms tumor.
Tiburcio PDB, Desai K, Kim J, Zhou Q, Guo L, Xiao X, Zhou L, Yuksel A, Catchpoole DR, Amatruda JF, Xu L, Chen KS, 2024 Apr Mol Cancer ResIntronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor.
Fraire CR, Mallinger PR, Hatton JN, Kim J, Dickens DS, Argenta PA, Milanovich S, Hartshorne T, Carey DJ, Haley JS, Urban G, Lee J, Hill DA, Stewart DR, Schultz KAP, Chen KS, 2023 Sep JCO Precis Oncol 7 e2300189Children's Oncology Group's 2023 blueprint for research: Rare tumors.
Schultz KAP, Chintagumpala M, Piao J, Chen KS, Gartrell R, Christison-Lagay E, Berry JL, Shah R, Laetsch TW, 2023 Jul Pediatr Blood Cancer e30574Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.
Schultz KAP, Chintagumpala M, Piao J, Chen KS, Shah R, Gartrell RD, Christison-Lagay E, Pashnakar F, Berry JL, O'Neill AF, Vasta LM, Flynn A, Mitchell SG, Seynnaeve BK, Rosenblum J, Potter SL, Kamihara J, Rodriguez-Galindo C, Hawkins DS, Laetsch TW, 2023 Dec EJC Paediatr Oncol 2Pitfalls in the diagnosis of yolk sac tumor: Lessons from a clinical trial.
Yang A, Patterson A, Pavlock T, Chen KS, Gagan J, Hatley ME, Frazier AL, Amatruda JF, Laetsch TW, Rakheja D, 2022 Feb Pediatr Blood Cancer 2 69 e29451Extrarenal Anaplastic Wilms Tumor: A Case Report With Genomic Analysis And Tumor Models.
Willis KR, Sathe AA, Xing C, Koduru P, Artunduaga M, Butler EB, Park JY, Kurmasheva RT, Houghton PJ, Chen KS, Rakheja D, 2022 Feb J Pediatr Hematol OncolIntegrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis.
Medvedev KE, Savelyeva AV, Chen KS, Bagrodia A, Jia L, Grishin NV, 2022 Cancer Inform 21 11769351221132634Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1
Chen KS, Stroup EK, Budhipramono A, Rakheja D, Nichols-Vinueza D, Xu L, Stuart SH, Shukla AA, Fraire C, Mendell JT, Amatruda JF 2018 Jul Genes Dev.EGF Receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors.
Chen KS, Fustino NJ, Shukla AA, Stroup EK, Budhipramono A, Ateek C, Stuart SH, Yamaguchi K, Kapur P, Frazier AL, Lum L, Looijenga LHJ, Laetsch TW, Rakheja D, Amatruda JF 2018 Feb Mol. Cancer Ther.A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma.
Chen KS, Kwon WS, Kim J, Heo SJ, Kim HS, Kim HK, Kim SH, Lee WS, Chung HC, Rha SY, Hwang TH 2016 Sep Cold Spring Harb Mol Case Stud 5 2 a000992Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides.
Chen KS, Bach A, Shoup A, Winick NJ 2013 Jun Pediatr Blood CancerDNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors.
Amatruda JF, Ross JA, Christensen B, Fustino NJ, Chen KS, Hooten AJ, Nelson H, Kuriger JK, Rakheja D, Frazier AL, Poynter JN 2013 BMC Cancer 1 13 313Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA 2001 May Blood 10 97 3146-51